214 related articles for article (PubMed ID: 26821059)
1. Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo.
Mahaling B; Katti DS
Int J Pharm; 2016 Mar; 501(1-2):1-9. PubMed ID: 26821059
[TBL] [Abstract][Full Text] [Related]
2. Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract.
Srinivasarao DA; Reddy SS; Reddy GB; Katti DS
Int J Pharm; 2019 Sep; 568():118474. PubMed ID: 31279055
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
4. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles for drug delivery to the anterior segment of the eye.
Janagam DR; Wu L; Lowe TL
Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306
[TBL] [Abstract][Full Text] [Related]
6. Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug.
Sasaki H; Yamamura K; Tei C; Nishida K; Nakamura J
J Drug Target; 1995; 3(2):129-35. PubMed ID: 7496726
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model.
Hafner A; Lovrić J; Romić MD; Juretić M; Pepić I; Cetina-Čižmek B; Filipović-Grčić J
Eur J Pharm Sci; 2015 Jul; 75():142-50. PubMed ID: 25869457
[TBL] [Abstract][Full Text] [Related]
8. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
[TBL] [Abstract][Full Text] [Related]
9. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake of coumarin-6 under microfluidic conditions into HCE-T cells from nanoscale formulations.
Pretor S; Bartels J; Lorenz T; Dahl K; Finke JH; Peterat G; Krull R; Al-Halhouli AT; Dietzel A; Büttgenbach S; Behrends S; Reichl S; Müller-Goymann CC
Mol Pharm; 2015 Jan; 12(1):34-45. PubMed ID: 25412253
[TBL] [Abstract][Full Text] [Related]
11. Charged nanoparticles delivery to the eye using hydrogel iontophoresis.
Eljarrat-Binstock E; Orucov F; Aldouby Y; Frucht-Pery J; Domb AJ
J Control Release; 2008 Mar; 126(2):156-61. PubMed ID: 18201790
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride.
Liu D; Lian Y; Fang Q; Liu L; Zhang J; Li J
Int J Biol Macromol; 2018 Sep; 116():1026-1036. PubMed ID: 29778883
[TBL] [Abstract][Full Text] [Related]
13. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
Nagai N; Ito Y; Okamoto N; Shimomura Y
Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
[TBL] [Abstract][Full Text] [Related]
14. New vehicle based on a microemulsion for topical ocular administration of dexamethasone.
Fialho SL; da Silva-Cunha A
Clin Exp Ophthalmol; 2004 Dec; 32(6):626-32. PubMed ID: 15575833
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-based nanoparticles for rosmarinic acid ocular delivery--In vitro tests.
da Silva SB; Ferreira D; Pintado M; Sarmento B
Int J Biol Macromol; 2016 Mar; 84():112-20. PubMed ID: 26645149
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
17. Effects of calcium chelating agents on corneal permeability.
Grass GM; Wood RW; Robinson JR
Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):110-3. PubMed ID: 3917988
[TBL] [Abstract][Full Text] [Related]
18. On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein.
Mun EA; Morrison PW; Williams AC; Khutoryanskiy VV
Mol Pharm; 2014 Oct; 11(10):3556-64. PubMed ID: 25165886
[TBL] [Abstract][Full Text] [Related]
19. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.
Grass GM; Robinson JR
J Pharm Sci; 1988 Jan; 77(1):3-14. PubMed ID: 3126290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
